India to United Kingdom: Febuxostat Export Trade Route
India has recorded 53 verified shipments of Febuxostat exported to United Kingdom, representing a combined trade value of $1.0M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $19.1K USD. The leading Indian exporter is MACLEODS PHARMACEUTICALS LTD, which accounts for 52% of total export value with 11 shipments worth $524.3K USD. On the buying side, MACLEODS PHARMA UK LIMITED is the largest importer in United Kingdom with $548.9K USD in purchases. The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, MSN LABORATORIES PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED — together control 82% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Febuxostat corridor is one of India's established pharmaceutical export routes, with 53 shipments documented worth a combined $1.0M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's febuxostat manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $19.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with febuxostat's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 14.0%, placing it at rank #3 among India's top febuxostat export destinations globally.
On the import side, key buyers of Indian febuxostat in United Kingdom include MACLEODS PHARMA UK LIMITED, TILLOMED LABORATORIES LTD, NA and 9 others. MACLEODS PHARMA UK LIMITED is the single largest importer with 14 shipments valued at $548.9K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ2
- Primary modeSea freight
- Top portHYDERABAD ICD
Market Position
- Global rank#3
- Annual growth+14.0%
- Demand growth+12.3%
- Regulatory ease71/100
Top 10 Indian Febuxostat Exporters to United Kingdom
Showing top 10 of 7 Indian suppliers exporting Febuxostat to United Kingdom, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD Avg $47.7K per shipment | 11 | $524.3K | 51.7% |
| 2 | MSN LABORATORIES PRIVATE LIMITED Avg $13.0K per shipment | 14 | $182.0K | 18.0% |
| 3 | EMCURE PHARMACEUTICALS LIMITED Avg $9.2K per shipment | 14 | $128.2K | 12.6% |
| 4 | INDOCO REMEDIES LIMITED Avg $20.3K per shipment | 4 | $81.0K | 8.0% |
| 5 | EMCURE PHARMACEUTICALS LTD Avg $12.3K per shipment | 6 | $73.6K | 7.3% |
| 6 | MACLEODS PHARMACEUTICALS LIMITED Avg $8.2K per shipment | 3 | $24.6K | 2.4% |
| 7 | NARAYANA HRUDAYALAYA LIMITED Avg $12 per shipment | 1 | $12 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting febuxostat to United Kingdom, ranked by total trade value. The listed exporters are: MACLEODS PHARMACEUTICALS LTD, MSN LABORATORIES PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED, INDOCO REMEDIES LIMITED, EMCURE PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LIMITED, NARAYANA HRUDAYALAYA LIMITED. MACLEODS PHARMACEUTICALS LTD is the dominant supplier with 11 shipments worth $524.3K USD, giving it a 52% market share. The top 3 suppliers together account for 82% of the total trade value on this route.
Top 10 Febuxostat Importers in United Kingdom
Showing top 10 of 12 known buyers in United Kingdom receiving Febuxostat shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian febuxostat in United Kingdom include MACLEODS PHARMA UK LIMITED, TILLOMED LABORATORIES LTD, NA, TILLOMED LABORATORIES LIMITED, MSN LABORATORIES EUROPE LIMITED, among 12 total buyers. The largest importer is MACLEODS PHARMA UK LIMITED, accounting for $548.9K USD across 14 shipments — representing 54% of all febuxostat imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMA UK LIMITED | 14 | $548.9K | 54.1% |
| 2 | TILLOMED LABORATORIES LTD | 10 | $122.3K | 12.1% |
| 3 | NA | 4 | $81.0K | 8.0% |
| 4 | TILLOMED LABORATORIES LIMITED | 7 | $79.6K | 7.8% |
| 5 | MSN LABORATORIES EUROPE LIMITED | 6 | $75.7K | 7.5% |
| 6 | MSN LABORATORIES EUROPE LIMITED., | 4 | $61.6K | 6.1% |
| 7 | MSN LABORATORIES EUROPE LIMITED C | 2 | $24.1K | 2.4% |
| 8 | TO THE ORDER OF | 1 | $11.5K | 1.1% |
| 9 | MSN LABORATORIES EUROPE LIMITED . | 1 | $9.1K | 0.9% |
| 10 | HEALTH CITY CAYMAN ISLANDS HCC | 1 | $12 | 0.0% |
Showing top 10 of 12 Febuxostat importers in United Kingdom on this route.
Top 10 Febuxostat Formulations Imported by United Kingdom
Showing top 10 of 39 product formulations shipped on the India to United Kingdom Febuxostat route, ranked by trade value
United Kingdom imports a wide range of febuxostat formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — FEBUXOSTAT 120MG TABLETS BNO:BFN2301A MFG. DT. SEP-2023 EXP. DT. AUG-2026 PS: 2X14S — accounts for $365.5K USD across 1 shipments. There are 39 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FEBUXOSTAT 120MG TABLETS BNO:BFN2301A MFG. DT. SEP-2023 EXP. DT. AUG-2026 PS: 2X14S | 1 | $365.5K | 36.1% |
| 2 | FEBUXOSTAT TABS 80 MG X 28'S MSN UK | 6 | $82.9K | 8.2% |
| 3 | FEBUXOSTAT 120MG TABLETS BNO:14242915A MFG DT:11/2024 EXP DT:10/2027 PS: 2X14S | 1 | $53.9K | 5.3% |
| 4 | FEBUXOSTAT TABLETS 80MG, PACK OF 2X14'S (EACH FILM COATED TABLET CONTAIN: FEBUXOSTAT 80MG) | 1 | $37.9K | 3.7% |
| 5 | FEBUXOSTAT 80MG TABLETS BNO:BFM2303A MFG | 1 | $29.3K | 2.9% |
| 6 | FEBUXOSTAT TABLETS 80MG, PACK OF 2X14S | 1 | $29.0K | 2.9% |
| 7 | FEBUXOSTAT 80MG TABLETS BATCH NO 14250778A MFG DT 02 2025 EXP DT 01 2028 | 1 | $24.7K | 2.4% |
| 8 | FEBUXOSTAT 80MG TABLETS BNO:BFM2305A MFG. DT. DEC-2023 EXP. DT. NOV-2026 PS: 2X14SNOS | 3 | $24.6K | 2.4% |
| 9 | FEBUXOSTAT 80MG TABLETS BNO:14240554B MFG DT:05/2024 EXP DT:04/2027 PS: 2X14S | 1 | $24.6K | 2.4% |
| 10 | MSN PHARMA -Febuxostat Tabs 80 mg X28'sMSN UK | 2 | $24.1K | 2.4% |
Showing top 10 of 39 Febuxostat formulations imported by United Kingdom on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 9 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's febuxostat exports to United Kingdom are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United Kingdom benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, MSN LABORATORIES PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED — together account for 82% of total trade value on this route. The average shipment value of $19.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as febuxostat tabs 80 mg x 28's msn uk and febuxostat 120mg tablets bno:14242915a mfg dt:11/2024 exp dt:10/2027 ps: 2x14s, suggesting that buyers in United Kingdom tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MACLEODS PHARMA UK LIMITED is the largest importer with 14 shipments worth $548.9K USD — representing 54% of all febuxostat imports from India on this route. A total of 12 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.0M
- Avg. Shipment
- $19.1K
- Suppliers
- 7
- Buyers
- 12
- Transit (Sea)
- ~21 days
- Annual Growth
- +14.0%
Related Analysis
Reverse Direction
United Kingdom → India — Febuxostat (Import)Other Febuxostat Routes
Febuxostat — Export Intelligence Video
Visual overview of India's febuxostat India to United Kingdom export trade route — top suppliers, destinations, pricing, and trade routes
Unlock the Full India to United Kingdom Febuxostat Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 53 shipments on this route.
Frequently Asked Questions — India to United Kingdom Febuxostat Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Febuxostat to United Kingdom?
The leading Indian exporters of Febuxostat to United Kingdom are MACLEODS PHARMACEUTICALS LTD, MSN LABORATORIES PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED. MACLEODS PHARMACEUTICALS LTD holds the largest market share at approximately 52% of total trade value on this route.
Q What is the total value of Febuxostat exports from India to United Kingdom?
India exports Febuxostat to United Kingdom worth approximately $1.0M USD across 53 recorded shipments. The average value per shipment is $19.1K USD.
Q Which ports does India use to ship Febuxostat to United Kingdom?
The most active port of origin is HYDERABAD ICD with 9 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 19% by air.
Q How long does shipping take from India to United Kingdom for Febuxostat?
The average transit time for Febuxostat shipments from India to United Kingdom is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United Kingdom Febuxostat trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 14.0% with demand growth tracking at 12.3%. The route is ranked #3 among India's top Febuxostat export destinations globally.
Q How many suppliers are active on the India to United Kingdom Febuxostat route?
There are currently 7 active Indian suppliers exporting Febuxostat to United Kingdom. The market is moderately concentrated with MACLEODS PHARMACEUTICALS LTD accounting for 52% of total shipment value.
Q Who are the main importers of Febuxostat from India in United Kingdom?
The leading importers of Indian Febuxostat in United Kingdom include MACLEODS PHARMA UK LIMITED, TILLOMED LABORATORIES LTD, NA, TILLOMED LABORATORIES LIMITED, MSN LABORATORIES EUROPE LIMITED. MACLEODS PHARMA UK LIMITED is the largest buyer with 14 shipments worth $548.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United Kingdom export trade corridor identified from Indian Customs (DGFT) records for Febuxostat.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 12 importers in United Kingdom matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 53 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
53 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists